Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01241656 · ClinicalTrials.gov registry record · NA

Decision Support Interventions (DESI) for Prostate Cancer Screening - Study 1

A NA study of Healthy Men Age 50 Who Are Considering PSA Screening, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
2,521
Enrollment target
2
Study locations

NCT01241656 is a NA study of Healthy Men Age 50 Who Are Considering PSA Screening that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 2,521 participants. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01241656, a NA study of Healthy Men Age 50 Who Are Considering PSA Screening, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
2,521 participants
Enrollment target
2
Study locations

Study Summary

In this study we will compare 3 strategies for systematic delivery of prostate cancer screening decision support interventions (DESI) to usual care and examine their impact on screening decisions and subsequent healthcare utilization using a randomized control design. We hypothesize men who are given the opportunity to review a DESI by one of the 3 strategies will be less likely to opt for prostate cancer screening, and will have lower subsequent healthcare utilization than men in the control group.

Interventions

  • BEHAVIORAL DESI for home viewing
  • BEHAVIORAL DESI for viewing at Shared Medical Appointment
  • BEHAVIORAL Option of SMA and DESI or DESI only

Study Locations (2)

California

  • Palo Alto Medical Foundation Research Institute - Palo Alto

North Carolina

  • University of North Carolina, Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 2,521 participants
Start Date 2011-01
Est. Completion 2012-12
Phase NA

What the Registry Record Tells You About NCT01241656

The ClinicalTrials.gov registry entry for NCT01241656 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,521 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Men Age 50 Who Are Considering PSA Screening appearing as the primary indexed condition, and to 3 interventions - of which DESI for home viewing is the first listed.

NCT01241656 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, North Carolina.

Frequently Asked Questions

What is clinical trial NCT01241656 about?

NCT01241656 is a clinical study titled "Decision Support Interventions (DESI) for Prostate Cancer Screening - Study 1". In this study we will compare 3 strategies for systematic delivery of prostate cancer screening decision support interventions (DESI) to usual care and examine their impact on screening decisions and subsequent healthcare utilization using a randomized control design. We hypothesize men who are giv...

What is the current status of trial NCT01241656?

This trial is currently completed. It is a NA study. The enrollment target is 2,521 participants. The study started on 2011-01. Estimated completion is 2012-12.

What conditions does trial NCT01241656 study?

This clinical trial studies the following conditions: Healthy Men Age 50 Who Are Considering PSA Screening.

What interventions are being tested in trial NCT01241656?

The interventions under investigation include: DESI for home viewing (BEHAVIORAL), DESI for viewing at Shared Medical Appointment (BEHAVIORAL), Option of SMA and DESI or DESI only (BEHAVIORAL).

Who is sponsoring clinical trial NCT01241656?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01241656 being conducted?

This trial has 2 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.